CN106266001A - 一种用于缓解血燥型银屑病的中药配方 - Google Patents
一种用于缓解血燥型银屑病的中药配方 Download PDFInfo
- Publication number
- CN106266001A CN106266001A CN201610995410.3A CN201610995410A CN106266001A CN 106266001 A CN106266001 A CN 106266001A CN 201610995410 A CN201610995410 A CN 201610995410A CN 106266001 A CN106266001 A CN 106266001A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- blood
- alleviating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 230000001185 psoriatic effect Effects 0.000 title claims abstract description 21
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 241000903946 Clematidis Species 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 241000825107 Hierochloe Species 0.000 claims description 2
- 235000015466 Hierochloe odorata Nutrition 0.000 claims description 2
- 206010015150 Erythema Diseases 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 231100000321 erythema Toxicity 0.000 abstract description 11
- 238000011282 treatment Methods 0.000 abstract description 5
- 230000003340 mental effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 description 11
- 201000004681 Psoriasis Diseases 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 7
- 208000002474 Tinea Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 241000130764 Tinea Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 206010037888 Rash pustular Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- RYZCLUQMCYZBJQ-UHFFFAOYSA-H lead(2+);dicarbonate;dihydroxide Chemical compound [OH-].[OH-].[Pb+2].[Pb+2].[Pb+2].[O-]C([O-])=O.[O-]C([O-])=O RYZCLUQMCYZBJQ-UHFFFAOYSA-H 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于缓解血燥型银屑病的中药配方,包括龙骨4‑17份,牡蛎3‑22份,龟板5‑15份,何首乌4‑15份,威灵仙6‑18份,白芍5‑18份,刺蒺藜4‑16份,甘草10‑30份,以及熟地、蝉衣和川芎,白芍选用杭白芍。本发明的中药组合物在使用过程中没有不良反应,而且对银屑病的治疗有明显的效果,选取的药物原料互相之间没有毒副作用,轻度和重度银屑病患者都可以使用,适用范围广,消除皮肤上的红斑和鳞屑,消除身体的火气,提高精神状态。
Description
技术领域
本发明涉及中药技术领域,具体是指一种用于缓解血燥型银屑病的中药配方。
背景技术
银屑病俗称牛皮癣,是一种慢性炎症性皮肤病,病程较长,有易复发倾向,有的病例几乎终生不愈。该病发病以青壮年为主,对患者的身体健康和精神状况影响较大。临床表现以红斑,鳞屑为主,全身均可发病,以头皮,四肢伸侧较为常见,多在冬季加重。
银屑病用牛皮癣一词来概括该病名称是十分不科学的,因为银屑病其实并不是癣。所谓“癣”,医学上是指由于真菌感染引起的一些皮肤病,例如头癣、股癣、体癣、手足癣、指甲癣等。将这些癣局部的皮屑放在显微镜下常能发现真菌菌丝或真菌使孢子,使用抗真菌药物进行治疗常能取得很好的疗效。其特征是出现大小不等的丘疹,红斑,表面覆盖着银白色鳞屑。而银屑病则不是由真菌感染引起的,医学上将其称为银屑病。它的发病原因很复杂,用抗真菌药物进行治疗往往无效。因此,有些病人会望文生义,自己服用抗真菌药物或者乱用癣药外涂,反而导致浪费钱财,加重病情。而且由于银屑病是由于身体内部出现异常,才引起外部皮肤受损和人精神心理层面的损伤,所以使用中药会对银屑病的治疗有很好的疗效。
发明内容
本发明的目的在于提供一种能显著消退红斑,鳞屑、减轻皮肤瘙痒感,提升身体的健康水平、去除身体燥热的中药组合物。
本发明通过下述技术方案实现:一种用于缓解血燥型银屑病的中药配方,按重量份计,包括:龙骨4-17份,牡蛎3-22份,龟板5-15份,何首乌4-15份,威灵仙6-18份,白芍5-18份,刺蒺藜4-16份,甘草10-30份。
本发明所述的一种用于缓解血燥型银屑病的中药配方的原料药药理:
龙骨:味甘、涩,性平。入心、肝、肾、大肠经。具有重镇安神,敛汗固精,止血涩肠,生肌敛疮的效果。治惊痫癫狂,怔忡健忘,失眠多梦,自汗盗汗,遗精淋浊,吐衄便血,崩漏带下,泻痢脱肛,溃疡久不收口。
牡蛎:性微寒,味咸。归肝经、胆经、肾经。重镇安神,潜阳补阴,软坚散结,煅牡蛎收敛固涩。属平肝息风药下属分类的平抑肝阳药。
龟板:味咸,性平。入心、脾、肝三经。滋阴,潜阳,补肾,健骨。治肾阴不足,骨蒸劳热,吐血,衄血,久咳,遗精,崩漏,带下,腰痛,骨痿,阴虚风动,久痢,久疟,痔疮,小儿囟门不合。
何首乌:性温,味苦、甘、涩。归肝经、肾经、心经。解毒、消痈、润肠通便。属泻下药下分类的润下药。
威灵仙:性温,味辛、咸。归膀胱经。祛风除湿、通络止痛。属祛风湿病下属分类的祛风湿散寒药。 白芍:性微寒,味苦、酸。归肝经、脾经。平肝止痛、养血调经、敛阴止汗。属补虚药下属分类的补血药。
刺蒺藜:味苦,性温。入肺、肝、肾三经。散风,明目,下气,行血。治头痛,身痒,目赤肿翳,胸满,咳逆,症瘕,乳难,痈疽,瘰疬。
甘草:性平,味甘。归心经、胃经、脾经、肺经。补脾益气、止咳祛痰、缓急定痛、调和药性。属补虚药下分类的补气药。
为优化药物的药物效果,进一步地,所述龙骨10份,牡蛎18份,龟板11份,何首乌7份,威灵仙11份,白芍15份,刺蒺藜14份,甘草20份。
进一步地,为了提高提取药物效果,本发明还包括:熟地3-23份,蝉衣5-25份,川芎4-15份。
进一步地,所述中药组合物包括以下重量份的原料:
龙骨10份,牡蛎18份,龟板11份,何首乌7份,威灵仙11份,白芍15份,刺蒺藜14份,甘草20份,熟地20份,蝉衣10份,川芎13份。
进一步地,所述白芍选用杭白芍。
本发明的中药组合物在使用过程中没有不良反应,而且对银屑病的治疗有明显的效果,选取的药物原料互相之间没有毒副作用,轻度和重度银屑病患者都可以使用,适用范围广,消除皮肤上的红斑和鳞屑,消除身体的火气,提高精神状态。
具体实施方式
下面结合实施例对本发明作进一步地详细说明,但本发明的实施方式不限于此,在不脱离本发明上述技术思想情况下,根据本领域普通技术知识和惯用手段,做出各种替换和变更,均应包括在本发明的范围内。
实施例1:
本实施例所述一种用于缓解血燥型银屑病的中药配方,按重量份计,包括:龙骨4-17份,牡蛎3-22份,龟板5-15份,何首乌4-15份,威灵仙6-18份,白芍5-18份,刺蒺藜4-16份,甘草10-30份。
本发明药物的制备方法,包括以下步骤:
(1)以重量份表示,称取龙骨5-15份,牡蛎5-20份,龟板5-10份,何首乌3-18份,威灵仙2-16份,白芍5-18份,刺蒺藜4-16份,甘草10-30份;
(2)将上述全部中药原料药,先行用清水或纯净水浸泡30分钟,浸泡用水量为0.9~1.1L;
(3)将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;
(4)先用武火使煎药容器中药液沸腾,再使用文火熬制,煎药时需搅拌2~3次;
(5)煎煮完成后,加适量清水或纯净水没过药物,进行第二次煎煮,煎煮火候方法同上;
(6)滤出药液,所获药液即为内服药物。
实施例2:
本实施例所述用于缓解血燥型银屑病的中药组合物,按重量份计,包括:龙骨10份,牡蛎18份,龟板11份,何首乌7份,威灵仙11份,白芍15份,刺蒺藜14份,甘草20份。
实施例3:
本实施例在上述实施例的基础上,进一步地,还包括熟地3-23份,蝉衣5-25份,川芎4-15份。即本用于缓解血燥型银屑病的中药组合物,按重量份计,包括:龙骨10份,牡蛎18份,龟板11份,何首乌7份,威灵仙11份,白芍15份,刺蒺藜14份,甘草20份,熟地20份,蝉衣10份,川芎13份
本实施例的其他部分与上述实施例相同,不再赘述。
实施例4
本实施例提供该用于缓解血燥型银屑病的中药组合物的毒理学试验,具体如下:
急性毒性试验:
试验观察,因无法测出LD50,故进行了最大给药量的测定。将实施例1制备的中药组合物溶解在灭菌生理盐水中,配置成溶液灌胃小鼠,结果显示,以药物最大给药浓度9.65生药/ml,最大给药体积50ml/kg于24小时内给小鼠灌胃给药两次,小鼠最大给药量为763.25g生药/kg,动物未出现不良反应及死亡,解剖观察各脏器未见异常。
长期毒性试验:
本试验应用SD大鼠80只,将实施例1制备的中药组合物溶解在灭菌生理盐水中,配置成溶液灌胃,设对照组及24g、35g、49g生药/kg剂量组,连续灌胃给药12周,观察本发明的中药组合物对动物各项指标的影响。试验结果表明,连续给药12周,本发明的中药组合物对大鼠的体重、摄食量、外周血象、凝血时间、心电图、脏器指数等均无明显影响;血液生化十二项指标测定结果,给药12周低剂量组BiLi值高于对照组(P<0.05);低剂量组、中剂量组TP值高于对照组(P<0.05),但均在正常生理范围之内,其它指标与对照组比较无明显差异。恢复期各给药组各项指标测定值与对照组比较均无明显差异。各组各脏器大体观察未见异常。
本发明药物的使用方法:直接内服。
利用本发明药物针对各种银屑病患者的临床统计资料:
经过200例患者的临床使用,其中男患者114,女患者86例,用药年龄对象20-64岁。其中最小20岁,最大64岁,平均年龄39岁。
典型病例:
1、闻某,女,53岁,家居。患者四肢关节伸侧患银屑病多年,经各种治疗均无效,一直未治愈。于两月前自述服药不当加重,全身及头部起红丘疹,逐渐扩展增大,其上覆盖银白色鳞屑,自觉瘙痒,抓后鳞屑脱落,可见小出血点,反复发作 。患者于2015 年4月13日来我处就诊,按标准诊断为银屑,使用本发明实施例2的组方内服15天后,脓疱及皮损开始消退,面积逐渐缩小,红斑色泽变淡,鳞屑逐渐变薄。20天后,脓疱全部消失,继续服药30天皮肤红斑鳞屑全部消失,皮肤光滑,仅存较淡色素沉着,痊愈。继续巩固服药20天,以加强疗效。随访至今未见复发。
2、孙某,男,32岁,工人。患者于一月前开始发病,全身起针头大小红疹,逐渐扩展变大,红疹上面出现银白色鳞屑,自觉瘙痒,骚抓后皮屑脱落,皮疹逐渐增大。于 2014年3月24日来我处就诊,诊断为急性银屑病。使用本发明实施例2的组方内服30天后复查,红斑、鳞屑明显减少,周身已不瘙痒,睡眠安稳,舌质红,脉平缓,续服前方。1个半月时复查,周身仅有少许红斑,其他皮损已消退,舌质红,苔薄,脉和缓,因其病久,嘱其再服药方半个月再来复查。到期复查时,周身已无红斑、鳞屑,皮肤光滑如初。
尽管已经示出和描述了本发明的实施例,本领域的普通技术人员可以理解:在不脱离本发明的原理和宗旨下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由权利要求及其等同物限定。
Claims (5)
1.一种用于缓解血燥型银屑病的中药配方,其特征在于,按重量份计,包括:龙骨4-17份,牡蛎3-22份,龟板5-15份,何首乌4-15份,威灵仙6-18份,白芍5-18份,刺蒺藜4-16份,甘草10-30份。
2.根据权利要求1所述的一种用于缓解血燥型银屑病的中药配方,其特征在于,所述龙骨10份,牡蛎18份,龟板11份,何首乌7份,威灵仙11份,白芍15份,刺蒺藜14份,甘草20份。
3.根据权利要求1或2所述的一种用于缓解血燥型银屑病的中药配方,其特征在于,按重量份计,还包括:熟地3-23份,蝉衣5-25份,川芎4-15份。
4.根据权利要求3所述的一种用于缓解血燥型银屑病的中药配方,其特征在于,该中药组合物包括以下重量份的原料:
龙骨10份,牡蛎18份,龟板11份,何首乌7份,威灵仙11份,白芍15份,刺蒺藜14份,甘草20份,熟地20份,蝉衣10份,川芎13份。
5.根据权利要求1或2所述的一种用于缓解血燥型银屑病的中药配方,其特征在于,所述白芍选用杭白芍。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610995410.3A CN106266001A (zh) | 2016-11-11 | 2016-11-11 | 一种用于缓解血燥型银屑病的中药配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610995410.3A CN106266001A (zh) | 2016-11-11 | 2016-11-11 | 一种用于缓解血燥型银屑病的中药配方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106266001A true CN106266001A (zh) | 2017-01-04 |
Family
ID=57721181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610995410.3A Withdrawn CN106266001A (zh) | 2016-11-11 | 2016-11-11 | 一种用于缓解血燥型银屑病的中药配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106266001A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520655A (zh) * | 2013-10-25 | 2014-01-22 | 梁轶聪 | 一种治疗寻常型银屑病的中药组合物及其制备方法 |
CN105943738A (zh) * | 2016-06-08 | 2016-09-21 | 尹晓彤 | 用于治疗银屑病的中药组合物 |
-
2016
- 2016-11-11 CN CN201610995410.3A patent/CN106266001A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520655A (zh) * | 2013-10-25 | 2014-01-22 | 梁轶聪 | 一种治疗寻常型银屑病的中药组合物及其制备方法 |
CN105943738A (zh) * | 2016-06-08 | 2016-09-21 | 尹晓彤 | 用于治疗银屑病的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102671054A (zh) | 治疗血栓性静脉炎的中药组合物 | |
CN102716334B (zh) | 一种驱寒化瘀的中药组合物 | |
CN106361947A (zh) | 一种用于治疗骨质疏松的中药制备方法 | |
CN106344686A (zh) | 一种能够加强筋骨的中药制备方法 | |
CN103285279A (zh) | 一种促进孕妇产后康复的中药组合物及应用 | |
CN103083616B (zh) | 一种治疗卵巢囊肿的中药 | |
CN102580030B (zh) | 具有降血糖功效的外用中药组合物、制剂及其制备方法 | |
CN107468857A (zh) | 一种能够治疗胃溃疡的中药制备方法 | |
CN104524524B (zh) | 一种治疗骨质疏松的药物及制备方法 | |
CN102512645A (zh) | 一种治疗寒湿腰痛的中药组合物 | |
CN102961561B (zh) | 一种治疗冠心病的中药组合物 | |
CN106266001A (zh) | 一种用于缓解血燥型银屑病的中药配方 | |
CN104888133A (zh) | 一种治疗冠心病的中药组合物 | |
CN104117018A (zh) | 一种治疗冠心病的中药组合物 | |
CN106822852A (zh) | 治疗冠心病的药物组合物、其制备工艺及用途 | |
CN103495079B (zh) | 一种治疗男性不育症的中药复方组合物及其制备方法及其应用 | |
CN103285108B (zh) | 一种治疗腰痛的中药组合物 | |
CN105902885A (zh) | 一种治疗肺癌的中药 | |
CN106309593A (zh) | 一种用于缓解血燥型银屑病的中药配方的制备方法 | |
CN106266351A (zh) | 一种用于治疗骨质疏松的中药配方 | |
CN105770374A (zh) | 一种治疗子宫肌瘤的中药组合物 | |
CN104771529A (zh) | 一种治疗肝肾亏虚型创伤性关节炎的药物及制备方法 | |
CN105147861A (zh) | 一种用于治疗病毒性皮肤病的中药组合物、口服剂及其制备方法 | |
CN106344683A (zh) | 一种消除皮肤红斑、鳞屑的中药配方的制备方法 | |
CN102028811B (zh) | 一种治疗消渴病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170104 |